General drug use-results surveillance of Phesgo for combination subcutaneous injection MA and IN - Unresectable advanced or recurrent HER2-positive colorectal cancer that has progressed after cancer chemotherapy
Not Applicable
Recruiting
- Conditions
- nresectable advanced or recurrent HER2-positive colorectal cancer that has progressed after cancer chemotherapy
- Registration Number
- JPRN-UMIN000052965
- Lead Sponsor
- Chugai Pharmaceutical Co. Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method